303 related articles for article (PubMed ID: 20407011)
1. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
Wang S; Raven JF; Koromilas AE
Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
[TBL] [Abstract][Full Text] [Related]
2. Stat1 phosphorylation determines Ras oncogenicity by regulating p27 kip1.
Wang S; Raven JF; Durbin JE; Koromilas AE
PLoS One; 2008; 3(10):e3476. PubMed ID: 18941537
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
Schepers H; Wierenga AT; Eggen BJ; Vellenga E
Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
[TBL] [Abstract][Full Text] [Related]
4. Skp2 is oncogenic and overexpressed in human cancers.
Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
[TBL] [Abstract][Full Text] [Related]
5. Skp2 inversely correlates with p27 and tuberin in transformed cells.
Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
Amino Acids; 2009 Jul; 37(2):257-62. PubMed ID: 18604603
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
[TBL] [Abstract][Full Text] [Related]
7. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
[TBL] [Abstract][Full Text] [Related]
8. Skp2 promotes adipocyte differentiation via a p27Kip1-independent mechanism in primary mouse embryonic fibroblasts.
Okada M; Sakai T; Nakamura T; Tamamori-Adachi M; Kitajima S; Matsuki Y; Watanabe E; Hiramatsu R; Sakaue H; Kasuga M
Biochem Biophys Res Commun; 2009 Feb; 379(2):249-54. PubMed ID: 19109928
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
[TBL] [Abstract][Full Text] [Related]
10. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H
Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
[TBL] [Abstract][Full Text] [Related]
12. p27 deregulation by Skp2 overexpression induced by the JAK2V617 mutation.
Furuhata A; Kimura A; Shide K; Shimoda K; Murakami M; Ito H; Gao S; Yoshida K; Tagawa Y; Hagiwara K; Takagi A; Kojima T; Suzuki M; Abe A; Naoe T; Murate T
Biochem Biophys Res Commun; 2009 Jun; 383(4):411-6. PubMed ID: 19364496
[TBL] [Abstract][Full Text] [Related]
13. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.
Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I
Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cell proliferation of Tenon's capsule fibroblast by S-phase kinase-interacting protein 2 targeting SiRNA through increasing p27 protein level.
Wang F; Qi LX; Su Y; Yan QH; Teng Y
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1475-82. PubMed ID: 19875654
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
Chiappetta G; De Marco C; Quintiero A; Califano D; Gherardi S; Malanga D; Scrima M; Montero-Conde C; Cito L; Monaco M; Motti ML; Pasquinelli R; Agosti V; Robledo M; Fusco A; Viglietto G
Endocr Relat Cancer; 2007 Jun; 14(2):405-20. PubMed ID: 17639054
[TBL] [Abstract][Full Text] [Related]
16. P27 expression is regulated by separate signaling pathways, downstream of Ras, in each cell cycle phase.
Sa G; Stacey DW
Exp Cell Res; 2004 Nov; 300(2):427-39. PubMed ID: 15475007
[TBL] [Abstract][Full Text] [Related]
17. [Expression variation and significance of Skp2 and p27(kip1) during the proliferation of Jurkat cells].
Lu JX; Wang YC; Shen AG; Zhao YM; Sun CL; Zhang DM; Cheng C
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):330-4. PubMed ID: 18953829
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.
Hershko DD
Cancer; 2008 Apr; 112(7):1415-24. PubMed ID: 18260093
[TBL] [Abstract][Full Text] [Related]
19. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
Zheng XY; Ding W; Xie LP; Chen ZD
Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
